Eli Lilly and Co., of Indianapolis, said that the EMA's Committee for Medicinal Products for Human Use recommended approval of insulin lispro 200 units/ml (proposed trade name: Humalog 200 units/ml Kwikpen) for the treatment of type 1 and type 2 diabetes in adults.